OSTX Stock Price Chart
OSTX Financial
OS Therapies Inc
$1.47
-9.25%
$-0.15
At close: Aug 17, 16:00:00 GMT-4
$1.47
0.34%
$0
Post-market: Aug 17, 21:42:45 GMT-4
Back
OS Therapies Inc (OSTX) Financial
Key Stats
Prev.Close
$1.62
Open
$1.58
Day's Range
$1.44 - $1.58
52 week range
$1.15 - $2.57
Volume
1.1M
Avg.Volume
704.7K
Dividend yield
--
EPS (TTM)
-1.05
Market Cap
$67.1M
What is OSTX?
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2024-08-01. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.
